PAVmed Inc. (PAVM)

Market Closed

12 Dec, 20:00

NASDAQ (CM)

0. 33

-0.02

-4.86%

6.27M Market Cap

- P/E Ratio

0% Div Yield

300,830 Volume

-5.85 Eps

$ 0.35

Previous Close

Day Range

0.33 0.36

Year Range

0.3 0.9

Want to track PAVM and more in your Portfolio? 🎯

Get Started For Free

PAVmed Inc. (PAVM) Shareholder/Analyst Call Prepared Remarks Transcript

Seekingalpha | 1 week ago

PAVmed Inc. (PAVM) Q1 2025 Earnings Call Transcript

PAVmed Inc. (NASDAQ:PAVM ) Q1 2025 Earnings Conference Call May 15, 2025 8:30 AM ET Company Participants Matt Riley - Senior Director of Investor Relations Lishan Aklog - Chairman and Chief Executive Officer Dennis McGrath - Chief Financial Officer Conference Call Participants Jeremy Pearlman - Maxim Group Edward Woo - Ascendiant Capital Operator Good morning, and welcome to the PAVmed's First Quarter 2025 Business Update Conference Call. At this time, all lines are in a listen-only mode.

Seekingalpha | 7 months ago

PAVmed (PAVM) Upgraded to Buy: Here's What You Should Know

PAVmed (PAVM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks | 7 months ago

PAVmed Inc. (PAVM) Q4 2024 Earnings Call Transcript

PAVmed Inc. (NASDAQ:PAVM ) Q4 2024 Earnings Conference Call March 25, 2025 8:30 AM ET Company Participants Matt Riley - Senior Director of IR Lishan Aklog - Chairman and CEO Dennis McGrath - CFO Conference Call Participants Jeremy Pearlman - Maxim Group Matthew Park - Cantor Fitzgerald Ed Woo - Ascendiant Capital Operator Good morning, and welcome to PAVmed's Fourth Quarter 2024 Business Update Conference Call. At this time, all lines are in a listen-only mode.

Seekingalpha | 8 months ago

PAVmed Inc. (PAVM) Q3 2024 Earnings Call Transcript

PAVmed Inc. (NASDAQ:PAVM ) Q3 2024 Earnings Call Transcript November 14, 2024 8:30 AM ET Company Participants Matt Riley - Director of IR Lishan Aklog - Chairman and CEO Dennis McGrath - CFO Conference Call Participants Ross Osborn - Cantor Fitzgerald Anthony Vendetti - Maxim Group Ed Woo - Ascendiant Capital Operator Good morning, and welcome to the PAVmed's Third Quarter 2024 Business Update Conference Call. At this time, all lines are in a listen-only mode.

Seekingalpha | 1 year ago

PAVmed Inc. (PAVM) Q2 2024 Earnings Call Transcript

PAVmed Inc. (NASDAQ:PAVM ) Q2 2024 Earnings Conference Call August 13, 2024 8:30 AM ET Company Participants Matt Riley - Director of IR Lishan Aklog - Chairman and CEO Dennis McGrath - CFO Conference Call Participants Matthew Park - Cantor Fitzgerald Anthony Vendetti - Maxim Group Ed Woo - Ascendiant Capitalized Operator Good morning and welcome to PAVmed's Second Quarter 2024 Business Update Conference Call. At this time, all lines are in a listen-only mode.

Seekingalpha | 1 year ago

Affiliate Program About Terms Privacy Help Contact Us